THE 14 BEST-PERFORMING CEOs
IN BIOTECH AND PHARMA

By Sy Mukherjee

Harvard Business Review released its annual list of the "best-performing" CEOs in the world - and there's a whole lot of familiar names for biotech, life sciences, and pharma junkies.

To compile the list, Harvard focused on tangible metrics such as long-term growth and market capitalization. Only CEOs who have served for at least two years were included in the rankings, and the Business Review considered variables such as return on shareholders' investments over the entire period of the CEOs' tenures (adjusted for both individual countries and industry-wide fluctuations) and market capitalization. As the researchers admit, this leaves out important "intangibles" such as strategic vision and employee and customer satisfaction, so the rankings are by no means perfect or definitive.

But they do offer some interesting insights into the performance of some of the most successful people in biotech, pharma, and healthcare. There were four people from the industry in the list's top 10, five in the top 20, 10 in the top 50, and 14 in the overall 100. Both the amounts and sources of compensation for these CEOs varied widely, with U.S. pharmaceutical and health IT giant McKesson's CEO raking in more than $25 million and Edwards Lifesciences' (which specializes in tissue and heart valve repair) head earning a more "modest" $6.6 million. Here are the highlights from the list:

1. John Martin, Gilead Sciences (#2 in overall ranking)

Based in: U.S.

MBA/Engineering degree: Both

Total industry-adjusted shareholder return: 6,919%

Total compensation: $15,451,862

2. David Pyott, Allergan (#4)

Based in: U.S.

MBA/Engineering degree: MBA

Total industry-adjusted shareholder return: 1,929%

Total compensation: $11,632,936

3. Lars Rebien Sørensen, Novo Nordisk (#6)

Based in: Denmark

MBA/Engineering degree: Neither

Total industry-adjusted shareholder return: 1,214%

Total compensation: $2,760,550

4. J. Michael Pearson, Valeant (#8)

Based in: Canada

MBA/Engineering degree: Both

Total industry-adjusted shareholder return: 1,100%

Total compensation: $6,997,734

5. George Paz, Express Scripts (#20)

Based in: U.S.

MBA/Engineering degree: Neither

Total industry-adjusted shareholder return: 419%

Total compensation: $13,040,682

6. Paul Bisaro, Actavis (#31)

Based in: U.S.

MBA/Engineering degree: Neither

Total industry-adjusted shareholder return: 475%

Total compensation: $11,024,994

7. Kent Thiry, DaVita (#37)

Based in: U.S.

MBA/Engineering degree: MBA

Total industry-adjusted shareholder return: 2,390%

Total compensation: $17,099,257

8. George Scangos, Biogen Idec (#40)

Based in: U.S.

MBA/Engineering degree: Neither

Total industry-adjusted shareholder return: 223%

Total compensation: $14,925,670

9. Ulf Schneider, Fresenius (#41)

Based in: Germany

MBA/Engineering degree: MBA

Total industry-adjusted shareholder return: 696%

Total compensation: $6,010,000

10. Joseph Papa, Perrigo (#47, tie)

Based in: U.S.

MBA/Engineering degree: MBA

Total industry-adjusted shareholder return: 669%

Total compensation: $6,146,036

11. John Hammergren, McKesson (#53)

Based in: U.S.

MBA/Engineering degree: MBA

Total industry-adjusted shareholder return: 200%

Total compensation: $25,032,775

12. Lars Rasmussen, Coloplast (#74)

Based in: Denmark

MBA/Engineering degree: Both

Total industry-adjusted shareholder return: 474%

Total compensation: $1,817,344

13. Michael Mussalem, Edwards Lifesciences (#86, tie)

Based in: U.S.

MBA/Engineering degree: Engineer

Total industry-adjusted shareholder return: 954%

Total compensation: $6,611,950

14. Jean-Paul Clozel, Actelion (#88)

Based in: Switzerland

MBA/Engineering degree: Neither

Total industry-adjusted shareholder return: 952%

Total compensation: $6,672,666

Fuente: BioPharmaDIVE

Haciendo click en cada uno de los links siguientes, 

accederán a los Contenidos de nuestros 

TALLERES DE CAPACITACIÓN IN COMPANY A MEDIDA:

(translator on page)

¿Cómo INCORPORAR y APLICAR Modelos de
PENSAMIENTO ESTRATÉGICO?
(aplicado al Sector Salud y Farma, con resolución de casos reales en tiempo real)

http://msg-latam-meic.blogspot.com.ar/2014/06/capacitacion-in-company-programa_6246.html

¿Cómo GERENCIAR EFICAZMENTE a partir del

MANAGEMENT ESTRATÉGICO?

(aplicado al Sector Salud y Farma, con resolución de casos reales en tiempo real)

http://msg-latam-meic.blogspot.com.ar/2014/06/capacitacion-in-company-programa_3.html

¿Cómo GERENCIAR PROCESOS DE CAMBIO

y no sufrir en el intento?

(aplicado al Sector Salud y Farma, con resolución de casos reales en tiempo real)

http://msg-latam-meic.blogspot.com.ar/2014/06/capacitacion-in-company-programa.html

¿Cómo IMPLEMENTAR ESTRATEGIAS EFECTIVAS?

Recetas para Escenarios Turbulentos

(aplicado al Sector Salud y Farma, con resolución de casos reales en tiempo real)

http://msg-latam-meic.blogspot.com.ar/2014/06/capacitacion-in-company-taller-de.html

Consultas al mail: msg.latam@gmail.com

ó al TE: +5411-3532-0510